3 Dimensional Ultrasound in Comparison to Hysteroscopy in Myomas
1 other identifier
observational
50
1 country
2
Brief Summary
• three-dimensional saline infusion sonohysterography (3D SIS) was performed in all cases. A sterile Cuscoe speculum was passed, the cervix visualized and cleaned with sterile chlorhexidine solution. A 3.3 mm soft plastic paediatric naso-gastric suction catheter was then passed through the cervix into the uterine cavity without grasping the cervix.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Feb 2021
Shorter than P25 for all trials
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 29, 2021
CompletedFirst Posted
Study publicly available on registry
February 3, 2021
CompletedStudy Start
First participant enrolled
February 7, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 15, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
May 17, 2021
CompletedMay 25, 2021
May 1, 2021
3 months
January 29, 2021
May 21, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
The accuracy of 3D ultrasound in doiagnosis of submucous myomas in comparison to hysteroscopy
How many women will be diagnosed by 3D US to have submucous myoma
one week
Study Arms (2)
3D ultrasound for diagnosis of submucous myomas
Hysteroscopy for diagnosis of submucous myoma
Interventions
Doing 3D ultrasound for diagnosis of submucous myoma
Doing hysteroscopy for diagnosis of submucous myoma
Eligibility Criteria
Women between 20 and 60 years with abnormal uterine bleeding
You may qualify if:
- Women between 20 and 60 years with abnormal uterine bleeding in form of heavy menstrual bleeding, irregular and heavy menstrual bleeding) diagnosed on non-enhanced two-dimensional ultrasonography with submucous fibroids.
- Absence of STD, PID, active vaginal bleeding.
You may not qualify if:
- Presence of general cause of abnormal uterine bleeding
- History of drug use that can cause vaginal bleeding (anticoagulants, OCPs, HRT)
- History of recent hormonal treatment
- High risk of undergoing hysteroscopy
- Vaginal, Vulval causes of bleeding
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Aljazeera Hospitallead
- Cairo Universitycollaborator
Study Sites (2)
Algazeerah
Giza, Egypt
Aljazeera( Al Gazeera) hospital
Giza, Egypt
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Mahmoud Alalfy, PhD
Algezeera hospitaland National Research Centre ,Egypt
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 29, 2021
First Posted
February 3, 2021
Study Start
February 7, 2021
Primary Completion
May 15, 2021
Study Completion
May 17, 2021
Last Updated
May 25, 2021
Record last verified: 2021-05